Fox Chase Cancer Center Researchers Uncover ONC201 Immune-oncology Effects
PHILADELPHIA ( [Anchor] March 20, 2018) – The Journal of Clinical Investigation recently published a scientific article describing ONC201’s ability to cause intratumoral accumulation and activation of natural killer (NK) and CD3+ T cells in mouse models and patients. The research is from the laboratory of Wafik El-Deiry MD, PhD, FACP, Scientific Founder of Oncoceutics, and Deputy Cancer Center Director for Translational Research at Fox Chase Cancer Center.